Literature DB >> 15919183

Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins.

Masaru Kitamura1, Shizunobu Igimi, Keiko Furukawa, Koichi Furukawa.   

Abstract

We assessed the response in knockout mice lacking the b-series (G(D2), G(D1b), G(T1b) and G(Q1b)) gangliosides against Clostridium botulinum (types A, B and E) and tetani toxins. We found that botulinum toxins were fully toxic, while tetanus toxin was much less toxic in the knockout mice. Combining the present results with our previous finding that tetanus toxin and botulinum types A and B toxins showed essentially no toxic activity in the knockout mice lacking both the a-series and b-series gangliosides (complex gangliosides), we concluded that the b-series gangliosides is the major essential substance for tetanus toxin, while b-series gangliosides may be not the essential substance for botulinum toxins, at the initial step during the intoxication process in mouse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919183     DOI: 10.1016/j.bbadis.2005.04.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Gangliosides as high affinity receptors for tetanus neurotoxin.

Authors:  Chen Chen; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri; Michael R Baldwin
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

2.  Clostridium perfringens alpha-toxin recognizes the GM1a-TrkA complex.

Authors:  Masataka Oda; Michiko Kabura; Teruhisa Takagishi; Ayaka Suzue; Kaori Tominaga; Shiori Urano; Masahiro Nagahama; Keiko Kobayashi; Keiko Furukawa; Koichi Furukawa; Jun Sakurai
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

3.  SV2 mediates entry of tetanus neurotoxin into central neurons.

Authors:  Felix L Yeh; Min Dong; Jun Yao; William H Tepp; Guangyun Lin; Eric A Johnson; Edwin R Chapman
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

4.  Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.

Authors:  M Zouhair Atassi; Midori Taruishi; Masooma Naqvi; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

5.  Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.

Authors:  Zhuji Fu; Chen Chen; Joseph T Barbieri; Jung-Ja P Kim; Michael R Baldwin
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

6.  Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.

Authors:  Faith C Blum; Amanda Przedpelski; William H Tepp; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

7.  A novel cholesterol-insensitive mode of membrane binding promotes cytolysin-mediated translocation by Streptolysin O.

Authors:  Cara C Mozola; N'Goundo Magassa; Michael G Caparon
Journal:  Mol Microbiol       Date:  2014-09-23       Impact factor: 3.501

Review 8.  Entering neurons: botulinum toxins and synaptic vesicle recycling.

Authors:  Claudia Verderio; Ornella Rossetto; Carlotta Grumelli; Carolina Frassoni; Cesare Montecucco; Michela Matteoli
Journal:  EMBO Rep       Date:  2006-10       Impact factor: 8.807

Review 9.  Receptor and substrate interactions of clostridial neurotoxins.

Authors:  Axel T Brunger; Andreas Rummel
Journal:  Toxicon       Date:  2009-03-04       Impact factor: 3.033

Review 10.  Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.

Authors:  Sheng Chen
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.